RxDoctor Payments DataLook up a doctor →

Peter Shalit, MD

Internal Medicine · Seattle, WANPI 1831181700

Payments from drug & device makers

$1,789,722in general payments, 2019–2025

Across 1,529 payments — averaging $1170.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$964K
  • Gilead$259K
  • Merck$252K
  • EMD Serono, Inc.$131K
  • AbbVie$79K
  • Janssen Scientific Affairs, LLC$42K
  • plus $63K from 29 others
$945,215in research payments, 2019–2025

Across 147 payments — averaging $6430.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$918K
  • Janssen Research & Development, LLC$18K
  • Seqirus USA Inc$8K
  • Viiv Healthcare Company$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,789,722 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington

Medicare billing

Part B allowed, 2024
$46,911
Medicare patients
88
Services billed
696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →